Synthetic Trial Acceleration
Leveraging synthetic digital twins to simulate control arms, reducing the recruitment burden and shortening drug launch cycles.
The Bottleneck
Life sciences companies are experiencing extended clinical trial timelines and exorbitant patient recruitment costs. Fragmented longitudinal patient data makes establishing control arms nearly impossible. External control arms only hold up when identity resolution and PHI minimisation are provable, not asserted.
Our Solution
We link encounter, claim, and clinical data into golden patient records. Using these unified data products, we simulate synthetic digital twins for control arms, drastically accelerating drug launch cycles.
Expected Engineering Outcomes
- Reduced recruitment burden
- HIPAA-compliant data mesh
- Shortened launch timelines
Execute this architecture
Ready to implement synthetic trial acceleration? Book a technical discovery call with our engineering team to review your current state.
Book Discovery Call